Healthify and Berry Street merge to build an insurance-covered AI metabolic care platform for the GLP-1 era.
A Nature Communications study pairs drug screening with machine learning against MPS IIIA.
The Colossal spin-off reaches a $3.8B valuation for AI that forecasts evolutionary change.
Outer Biosciences sustains surgically discarded tissue for a month to build better models.
A Munich crossover study of four commercial tools found speed gains but no accuracy lift.
Tempus ECG-PH reads standard 12-lead tracings for signs of elevated pulmonary artery pressure.
MaxQ Medical banks $31.5M from Olympus and others for a transurethral ultrasound and therapy platform.
New screens show AI-designed minibinders hit PD-L1 but struggle on other cancer targets.